SAB Biotherapeutics Reports Full Year 2023 Operating and Fin

Sioux Falls, SD , March 29, 2024 -- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results March 29, 2024 SAB-142 Phase 1 trial on track for data release during 2024 ...

Related Keywords

New York , United States , Andrew Moin , Katie Ellias , Samuelj Reich , Erick Lucera , Michaelg King Jr , Rd Fund , Twitter , Biotherapeutics Inc , Exchange Commission , Globenewswire Inc , Linkedin , Nasdaq , Sioux Falls , Reports Full Year , Recent Corporate Developments , Chief Financial , Leadership Committee , New York City Chapter , Managing Partner , Veralox Therapeutics , Chief Financial Officer , Virtual Conference , Private Securities Litigation Reform Act , Investor Relations , Markets ,